Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck

NCT02624128 2023-11-13

V-CHANCE

Phase 2 Unknown

39 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06081582 2023-10-13

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

Phase 2 Unknown

33 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05751512 2023-03-02

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Phase 3 Unknown

180 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04359199 2023-02-10

QUASAR

Unknown

42 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT02054442 2021-03-12

COMMENCE

Phase 1/2 Unknown

52 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02507154 2018-08-21

NKEXPHNC

Phase 1/2 Unknown

31 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

NCT00999700 2017-09-05

INTERCEPTOR

Phase 3 Unknown

282 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01874171 2017-05-08

De-ESCALaTE

Phase 3 Unknown

334 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02753140 2016-04-27

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

Phase 2 Unknown

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01830556 2013-05-21

CETMET

Phase 2 Unknown

120 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01301248 2011-05-17

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Phase 2 Unknown

80 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Clinical Trials

CZCNRHNSCC

V-CHANCE

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

QUASAR

COMMENCE

NKEXPHNC

INTERCEPTOR

De-ESCALaTE

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

CETMET

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck